New treatment target study for metastatic prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial studies a new therapy target for people with prostate cancer that has spread to other parts of the body. You may be a candidate if you can provide a cancer tissue sample and are able to consent to the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed prostate cancer based on tissue testing
- Your cancer has spread (metastatic disease) shown on scans or imaging
- Your doctors believe you can safely have a surgery or biopsy to get a tissue sample
- You can be willing and able to sign informed consent to join the study
- No other cancer type is diagnosed besides prostate cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a surgery called TURP (transurethral resection of the prostate) to the usual hormone therapy and chemotherapy can help men with metastatic prostate cancer that has spread to lymph nodes, bone, or other organs. The surgery helps relieve urinary symptoms and may improve how well the cancer responds to treatment.
This trial studies the “microenvironment” around prostate cancer metastases, using specimens taken during biopsy and other scans. It may help researchers understand what drives prostate cancer spread and improve future treatment choices.
This trial tests whether giving intense hormone therapy along with either radiation or surgery can help men with prostate cancer that has spread to a limited number of spots (10 or fewer) but not to organs like the liver or lungs. The goal is to treat both the main tumor and the visible metastatic spots more aggressively.
This study analyzes tumor tissue and blood samples from men with advanced prostate cancer to understand genetic changes that may affect treatment choices. Results may help doctors personalize your treatment plan.
This trial studies a treatment that targets a protein called PSMA in people with prostate cancer. It may help shrink or control the cancer and is being tested in different risk groups and stages of disease.
This study follows men with advanced prostate cancer that has spread to other parts of the body. It aims to learn more about how the disease and treatments affect patients over time, so doctors can improve care.
Hear when a new Prostate Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.